--- title: Newsroom | Healthcare (2) description: Healthcare | (2) --- [![Life Science Newswire 2](https://news.lifesciencenewswire.com/hs-fs/hubfs/Life%20Science%20Newswire%202.png?width=203&height=60&name=Life%20Science%20Newswire%202.png "Life Science Newswire 2")](https://lifesciencenewswire.com/) - [Newsroom](https://news.lifesciencenewswire.com/newsroom) - [Back to the main site](https://lifesciencenewswire.com/) ![LSNewswire-main-header-banner-v2-1](https://news.lifesciencenewswire.com/hubfs/LSNewswire-main-header-banner-v2-1.jpg "LSNewswire-main-header-banner-v2-1") # Newsroom #### Categories ![Arrow](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/sidebar.svg "Arrow") #### Subscribe![](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/subscribe-rss-button.svg) ![](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/close-button.svg) ### Choose a Category - [Agriculture (1)](https://news.lifesciencenewswire.com/newsroom/tag/agriculture) - [AI (2)](https://news.lifesciencenewswire.com/newsroom/tag/ai) - [Analytical Chemistry (42)](https://news.lifesciencenewswire.com/newsroom/tag/analytical-chemistry) - [Biomanufacturing (35)](https://news.lifesciencenewswire.com/newsroom/tag/biomanufacturing) - [biopharma (23)](https://news.lifesciencenewswire.com/newsroom/tag/biopharma) - [Bioprocessing (16)](https://news.lifesciencenewswire.com/newsroom/tag/bioprocessing) - [Biotechnology (252)](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology) - [Cell Culture (10)](https://news.lifesciencenewswire.com/newsroom/tag/cell-culture) - [Clinical Diagnostics (38)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-diagnostics) - [clinical research (6)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research) - [Clinical Research & Trials (117)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research-trials) - [Computing & Technology (62)](https://news.lifesciencenewswire.com/newsroom/tag/computing-it) - [Corporate, Finance & Investor (288)](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor) - [COVID-19 (86)](https://news.lifesciencenewswire.com/newsroom/tag/covid-19) - [Diagnostics & Hospital Laboratory (38)](https://news.lifesciencenewswire.com/newsroom/tag/diagnostics-hospital-laboratory) - [Digital Pathology (2)](https://news.lifesciencenewswire.com/newsroom/tag/digital-pathology) - [Drug Discovery & Development (153)](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development) - [Energy & Environment (15)](https://news.lifesciencenewswire.com/newsroom/tag/energy-environment) - [excipients (1)](https://news.lifesciencenewswire.com/newsroom/tag/excipients) - [Food & Beverage (8)](https://news.lifesciencenewswire.com/newsroom/tag/food-beverage) - [General Chemistry (7)](https://news.lifesciencenewswire.com/newsroom/tag/general-chemistry) - [General Laboratory (58)](https://news.lifesciencenewswire.com/newsroom/tag/general-laboratory) - [General Science (5)](https://news.lifesciencenewswire.com/newsroom/tag/general-science) - [Healthcare (136)](https://news.lifesciencenewswire.com/newsroom/tag/healthcare) - [Hospital Management (7)](https://news.lifesciencenewswire.com/newsroom/tag/hospital-management) - [Life Science (26)](https://news.lifesciencenewswire.com/newsroom/tag/life-science) - [Manufacturing (2)](https://news.lifesciencenewswire.com/newsroom/tag/manufacturing) - [Materials Science (2)](https://news.lifesciencenewswire.com/newsroom/tag/materials-science) - [Medical Devices & Technology (26)](https://news.lifesciencenewswire.com/newsroom/tag/medical-devices-technology) - [Microbiology & Infection Control (18)](https://news.lifesciencenewswire.com/newsroom/tag/microbiology-infection-control) - [Microscopy & Imaging (47)](https://news.lifesciencenewswire.com/newsroom/tag/microscopy-imaging) - [Nanotech (2)](https://news.lifesciencenewswire.com/newsroom/tag/nanotech) - [Omics & Genetics (87)](https://news.lifesciencenewswire.com/newsroom/tag/omics-genetics) - [Pathology (5)](https://news.lifesciencenewswire.com/newsroom/tag/pathology) - [Pharma (118)](https://news.lifesciencenewswire.com/newsroom/tag/pharma) - [Pharmacy (5)](https://news.lifesciencenewswire.com/newsroom/tag/pharmacy) - [Research (47)](https://news.lifesciencenewswire.com/newsroom/tag/research) - [Veterinary (6)](https://news.lifesciencenewswire.com/newsroom/tag/veterinary) - [Water (8)](https://news.lifesciencenewswire.com/newsroom/tag/water) See all ### Subscribe to Email Updates Categories: [Healthcare](https://news.lifesciencenewswire.com/newsroom/tag/healthcare), [Corporate, Finance & Investor](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor), [Clinical Diagnostics](https://news.lifesciencenewswire.com/newsroom/tag/clinical-diagnostics) #### [PrecisionLife appoints Bill Keating as Chief Commercial Officer, Diagnostics and Healthcare](https://news.lifesciencenewswire.com/newsroom/precisionlife-appoints-bill-keating-as-chief-commercial-officer-diagnostics-and-healthcare) January 8, 2025 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/precisionlife-appoints-bill-keating-as-chief-commercial-officer-diagnostics-and-healthcare) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/precisionlife-appoints-bill-keating-as-chief-commercial-officer-diagnostics-and-healthcare#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Jan 8, 2025, 2:00:00 PM - [Tweet](https://twitter.com/share) Categories: [Healthcare](https://news.lifesciencenewswire.com/newsroom/tag/healthcare), [Computing & Technology](https://news.lifesciencenewswire.com/newsroom/tag/computing-it), [Drug Discovery & Development](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development), [Corporate, Finance & Investor](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor), [Clinical Diagnostics](https://news.lifesciencenewswire.com/newsroom/tag/clinical-diagnostics) #### [Leica Biosystems and Indica Labs announce significant strategic investment and creation of digital pathology platform](https://news.lifesciencenewswire.com/newsroom/the-institute-of-tissue-medicine-of-the-university-of-bern-chooses-indica-labs-halo-ap-to-become-the-first-public-health-institute-in-switzerland-to-dep-1733764810962) January 8, 2025 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/the-institute-of-tissue-medicine-of-the-university-of-bern-chooses-indica-labs-halo-ap-to-become-the-first-public-health-institute-in-switzerland-to-dep-1733764810962) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/the-institute-of-tissue-medicine-of-the-university-of-bern-chooses-indica-labs-halo-ap-to-become-the-first-public-health-institute-in-switzerland-to-dep-1733764810962#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Jan 8, 2025, 1:13:03 PM - [Tweet](https://twitter.com/share) Categories: [Healthcare](https://news.lifesciencenewswire.com/newsroom/tag/healthcare), [Clinical Research & Trials](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research-trials), [Corporate, Finance & Investor](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor) #### [ENEA-Tech Biomedical Foundation invests €6m in BetaGlue® Therapeutics brings 2024 funding round total to €24m](https://news.lifesciencenewswire.com/newsroom/enea-tech-biomedical-foundation-invests-6m-in-betaglue-therapeutics-brings-2024-funding-round-total-to-24m) December 16, 2024 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/enea-tech-biomedical-foundation-invests-6m-in-betaglue-therapeutics-brings-2024-funding-round-total-to-24m) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/enea-tech-biomedical-foundation-invests-6m-in-betaglue-therapeutics-brings-2024-funding-round-total-to-24m#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Dec 16, 2024, 1:30:00 PM - [Tweet](https://twitter.com/share) Categories: [Healthcare](https://news.lifesciencenewswire.com/newsroom/tag/healthcare), [Clinical Research & Trials](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research-trials) #### [Ceryx Medical initiates first-in-human study of the Cysoni™ RSA Pacemaker](https://news.lifesciencenewswire.com/newsroom/ceryx-medical-initiates-first-in-human-study-of-the-cysoni-rsa-pacemaker) December 9, 2024 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/ceryx-medical-initiates-first-in-human-study-of-the-cysoni-rsa-pacemaker) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/ceryx-medical-initiates-first-in-human-study-of-the-cysoni-rsa-pacemaker#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Dec 9, 2024, 12:00:00 PM - [Tweet](https://twitter.com/share) Categories: [Healthcare](https://news.lifesciencenewswire.com/newsroom/tag/healthcare), [Corporate, Finance & Investor](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor), [Life Science](https://news.lifesciencenewswire.com/newsroom/tag/life-science) #### [Supreme Group acquires Amendola, an award-winning healthcare, health tech and life sciences PR and marketing agency](https://news.lifesciencenewswire.com/newsroom/supreme-group-acquires-amendola-an-award-winning-healthcare-health-tech-and-life-sciences-pr-and-marketing-agency) December 4, 2024 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/supreme-group-acquires-amendola-an-award-winning-healthcare-health-tech-and-life-sciences-pr-and-marketing-agency) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/supreme-group-acquires-amendola-an-award-winning-healthcare-health-tech-and-life-sciences-pr-and-marketing-agency#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Dec 4, 2024, 2:37:46 PM - [Tweet](https://twitter.com/share) Categories: [Healthcare](https://news.lifesciencenewswire.com/newsroom/tag/healthcare), [Pharma](https://news.lifesciencenewswire.com/newsroom/tag/pharma), [Corporate, Finance & Investor](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor) #### [Tillotts Pharma partners with Pioneer for the marketing and distribution of Tillotts\` product Asacol® in the People’s Republic of China](https://news.lifesciencenewswire.com/newsroom/tillotts-pharma-partners-with-pioneer-for-the-marketing-and-distribution-of-tillotts-product-asacol-in-the-peoples-republic-of-china) November 27, 2024 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/tillotts-pharma-partners-with-pioneer-for-the-marketing-and-distribution-of-tillotts-product-asacol-in-the-peoples-republic-of-china) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/tillotts-pharma-partners-with-pioneer-for-the-marketing-and-distribution-of-tillotts-product-asacol-in-the-peoples-republic-of-china#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Nov 27, 2024, 9:00:00 AM - [Tweet](https://twitter.com/share) Categories: [Diagnostics & Hospital Laboratory](https://news.lifesciencenewswire.com/newsroom/tag/diagnostics-hospital-laboratory), [Healthcare](https://news.lifesciencenewswire.com/newsroom/tag/healthcare), [Corporate, Finance & Investor](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor) #### [Sakura Finetek Europe and MEDIPATH announced their collaboration to improve patient journey for cancer screenings and diagnoses](https://news.lifesciencenewswire.com/newsroom/sakura-finetek-europe-and-medipath-announced-their-collaboration-to-improve-patient-journey-for-cancer-screenings-and-diagnoses) November 19, 2024 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/sakura-finetek-europe-and-medipath-announced-their-collaboration-to-improve-patient-journey-for-cancer-screenings-and-diagnoses) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/sakura-finetek-europe-and-medipath-announced-their-collaboration-to-improve-patient-journey-for-cancer-screenings-and-diagnoses#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Nov 19, 2024, 7:30:00 AM - [Tweet](https://twitter.com/share) Categories: [Healthcare](https://news.lifesciencenewswire.com/newsroom/tag/healthcare), [Clinical Research & Trials](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research-trials) #### [Two new scoping reviews of heated tobacco science by Imperial Brands further substantiate the category's tobacco harm reduction potential](https://news.lifesciencenewswire.com/newsroom/two-new-scoping-reviews-of-heated-tobacco-science-by-imperial-brands-further-substantiate-the-categorys-tobacco-harm-reduction-potential) August 12, 2024 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/two-new-scoping-reviews-of-heated-tobacco-science-by-imperial-brands-further-substantiate-the-categorys-tobacco-harm-reduction-potential) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/two-new-scoping-reviews-of-heated-tobacco-science-by-imperial-brands-further-substantiate-the-categorys-tobacco-harm-reduction-potential#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Aug 12, 2024, 12:00:00 PM - [Tweet](https://twitter.com/share) Categories: [Healthcare](https://news.lifesciencenewswire.com/newsroom/tag/healthcare), [Clinical Research & Trials](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research-trials) #### [Trial approval for new pacemaker aiming to boost recovery in heart failure](https://news.lifesciencenewswire.com/newsroom/trial-approval-for-new-pacemaker-aiming-to-boost-recovery-in-heart-failure) July 23, 2024 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/trial-approval-for-new-pacemaker-aiming-to-boost-recovery-in-heart-failure) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/trial-approval-for-new-pacemaker-aiming-to-boost-recovery-in-heart-failure#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Jul 23, 2024, 1:30:00 PM - [Tweet](https://twitter.com/share) [Previous](https://news.lifesciencenewswire.com/newsroom/tag/healthcare/page/1) [All posts](https://news.lifesciencenewswire.com/newsroom/all) [Next](https://news.lifesciencenewswire.com/newsroom/tag/healthcare/page/3) ##### Browse more news ## Recent releases #### [Ceryx Medical manufactures first implantable heart failure device at King’s College London’s MAISI f...](https://news.lifesciencenewswire.com/newsroom/ceryx-medical-manufactures-first-implantable-heart-failure-device-at-kings-college-londons-maisi-facility) October 22, 2026 A first for both organisations: the first implantable device built by the UK’s national active implant manufacturing facility is Ceryx’s bioelectronic... ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/ceryx-medical-manufactures-first-implantable-heart-failure-device-at-kings-college-londons-maisi-facility) #### [Scope’s CRISPR Molecular Diagnostics CE Marked for Antifungal Resistance](https://news.lifesciencenewswire.com/newsroom/scopes-crispr-molecular-diagnostics-ce-marked-for-antifungal-resistance) October 6, 2026 Developed with AmplexDiagnostics, eazySNP brings scopeDx® into human diagnostics Scope Biosciences B.V., a Wageningen University spinoff life sciences... ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/scopes-crispr-molecular-diagnostics-ce-marked-for-antifungal-resistance) #### [CellCarta Establishes Strategic Partnership with Waters to Advance Companion Diagnostics Development](https://news.lifesciencenewswire.com/newsroom/cellcarta-establishes-strategic-partnership-with-waters-to-advance-companion-diagnostics-development) October 5, 2026 Collaboration combines CellCarta’s global clinical trial testing capabilities with Waters’ standardized flow cytometry platforms and expertise CellCar... ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/cellcarta-establishes-strategic-partnership-with-waters-to-advance-companion-diagnostics-development) ![LS-Newswire-reverse](https://news.lifesciencenewswire.com/hs-fs/hubfs/raw_assets/public/LifeScienceNewswire_June2020/images/LS-Newswire-reverse.png?width=150&name=LS-Newswire-reverse.png "LS-Newswire-reverse") Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225  #### Useful information - [Cookie and privacy policy](https://lifesciencenewswire.com/cookie-privacy-policy/) - [Website terms and conditions](https://lifesciencenewswire.com/terms-and-conditions) - [Promotion terms and conditions](https://lifesciencenewswire.com/promotion_terms/)